U-Blot® Research Grade MipletamigCat. No. WA3160$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade MipletamigCat. No. WA3160
U-Blot® Research Grade MipasetamabCat. No. WA3159
U-Blot® Research Grade MinretumomabCat. No. WA3158
U-Blot® Research Grade minokitugCat. No. WA3157
U-Blot® Research Grade MilatuzumabCat. No. WA3156
U-Blot® Research Grade MicvotabartCat. No. WA3155
U-Blot® Research Grade MibavademabCat. No. WA3154
U-Blot® Research Grade MezagitamabCat. No. WA3153
U-Blot® Research Grade MevonlerbartCat. No. WA3152
U-Blot® Research Grade MetelimumabCat. No. WA3151
U-Blot® Research Grade merinetugCat. No. WA3150
U-Blot® Research Grade MepolizumabCat. No. WA3149